8/8 and 10/10 High-Resolution Match Rate for the Be The Match Unrelated Donor Registry  Jason Dehn, Kelly Buck, Martin Maiers, Dennis Confer, Robert Hartzman,

Slides:



Advertisements
Similar presentations
A Simplified Procedure for Hematopoietic Stem Cell Amplification Using a Serum-Free, Feeder Cell-Free Culture System Ian M. Rogers, Nobuko Yamanaka, Robert.
Advertisements

East Meets West—Impact of Ethnicity on Donor Match Rates in the Ezer Mizion Bone Marrow Donor Registry  Michael Halagan, Sigal Manor, Nira Shriki, Isaac.
Alexander H. Schmidt, Thilo Mengling, Camila J
Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
Improvement of Disease Status Determination and Documentation Pre- and Post- Transplant  Michelle Bycko, Crystal Gazaway, Jennifer Holter Chakrabarty,
How to Treat MDS without Stem Cell Transplantation
The Effect of the Composition of Unrelated Donor Bone Marrow and Peripheral Blood Progenitor Cell Grafts on Transplantation Outcomes  Nancy H. Collins,
Vaccination of Children following Allogeneic Stem Cell Transplantation
National Marrow Donor Program HLA Matching Guidelines for Unrelated Adult Donor Hematopoietic Cell Transplants  Robert A. Bray, Carolyn K. Hurley, Naynesh.
World Marrow Donor Association Crisis Response, Business Continuity, and Disaster Recovery Guidelines  Julia Pingel, Cullen Case, Beth Amer, Raymond A.
Major ABO Blood Group Mismatch Increases the Risk for Graft Failure after Unrelated Donor Hematopoietic Stem Cell Transplantation  Mats Remberger, Emma.
Transplantation of Umbilical Cord Blood–Derived Cells for Novel Indications in Regenerative Therapy or Immune Modulation: A Scoping Review of Clinical.
Twenty Years of Unrelated Donor Hematopoietic Cell Transplantation for Adult Recipients Facilitated by the National Marrow Donor Program  Chatchada Karanes,
Sabina Kersting, Leo F. Verdonck 
Access to Hematopoietic Cell Transplantation in the United States
Significance of Ethnicity in the Risk of Acute Graft-versus-Host Disease and Leukemia Relapse after Unrelated Donor Hematopoietic Stem Cell Transplantation 
Navneet S. Majhail, Elizabeth A. Murphy, Nancy A
Jane Kempenich, Kelly Buck, John Hermanson, Jason Dehn, MPH 
David S. Allan, Sarah Takach, Susan Smith, Mindy Goldman 
Motivations, Experiences, and Perspectives of Bone Marrow and Peripheral Blood Stem Cell Donors: Thematic Synthesis of Qualitative Studies  Maria C. Garcia,
Jennifer Crombie, Laura Spring, Shuli Li, Robert J. Soiffer, Joseph H
Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow.
A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model  Justin N. Baker,
Controversies in Lymphoma: The Role of Hematopoietic Cell Transplantation for Mantle Cell Lymphoma and Peripheral T Cell Lymphoma  Peter Dreger, Ginna.
Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program  Margaret L.
Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era  Navneet S. Majhail, Pintip Chitphakdithai,
Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation  Laurie H. Sehn, Timothy S. Fenske, Ginna G. Laport 
John R. Wingard, M. D. , Alan K. Leahigh, Dennis Confer, M. D
A Randomized Trial of One versus Two Doses of Influenza Vaccine after Allogeneic Transplantation  Nicole A. Karras, Matthew Weeres, Wendy Sessions, Xiyan.
Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies  Stefan O. Ciurea, Richard.
Relationship of Race/Ethnicity and Survival after Single Umbilical Cord Blood Transplantation for Adults and Children with Leukemia and Myelodysplastic.
HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease  Anna B. Pawlowska, Jerry C. Cheng,
B Cells and Transplantation: An Educational Resource
On Modeling Human Leukocyte Antigen–Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an.
Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients.
High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry  Kelly Buck, Kim Wadsworth, Michelle Setterholm, Martin.
Hematopoietic Cell Transplantation for Children with Acute Lymphoblastic Leukemia in Second Complete Remission: Similar Outcomes in Recipients of Unrelated.
Allogeneic Stem Cell Transplantation for Aplastic Anemia
The Hematopoietic Cell Transplant Pharmacist: Roles, Responsibilities, and Recommendations from the ASBMT Pharmacy Special Interest Group  Amber B. Clemmons,
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
HLA-Mismatched, Noninherited Maternal Antigen–Matched Unrelated Cord Blood Transplantations Have Superior Survival: How HLA Typing the Cord Blood Donor's.
ASBMT and CBMTG Release Choosing Wisely BMT Recommendations
Gerard Socié, K. Scott Baker, Smita Bhatia 
What is quality in a transplant program?
Issues of Aging and Geriatric Medicine: Relevance to Cancer Treatment and Hematopoietic Reconstitution  William B. Ershler, Andrew S. Artz, Evan T. Keller 
Identification of DPB1 Permissive Unrelated Donors Is Highly Likely
HapLogic: A Predictive Human Leukocyte Antigen–Matching Algorithm to Enhance Rapid Identification of the Optimal Unrelated Hematopoietic Stem Cell Sources.
T Cell–Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an.
Karen K. Ballen, Roberta J. King, Pintip Chitphakdithai, Charles D
Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond  Stanley R. Riddell, Michael C. Jensen, Carl.
HLA-Allele Matched Unrelated Donors Compared to HLA-Matched Sibling Donors: Role of Cell Source and Disease Risk Category  Ann Woolfrey, Stephanie J.
Biology of Blood and Marrow Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD–Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-
Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV?  Marie von Lilienfeld-Toal, MD, Maria Gilleece,
Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match  Jason Dehn, Mukta Arora, Stephen Spellman, Michelle Setterholm,
Blood and Marrow Transplant Handbook
Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives  Brenda M. Sandmaier, Stephen Mackinnon, Richard.
Treatment versus Transplant for Challenging Hematologic Disorders
Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions to Predict Survival  Daniel Weisdorf,
Transplantation of Unrelated Donor Umbilical Cord Blood for Nonmalignant Diseases: a Single Institution's Experience with 45 Patients  Tang-Her Jaing,
Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies  Mary Eapen, Paul O'Donnell,
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation  Eric Davis, Sean Devlin, Candice Cooper,
Mary Eapen  Biology of Blood and Marrow Transplantation 
Futility of Relapsed Diffuse Large B Cell Lymphoma Transplantation?
In Memoriam: E. Donnall Thomas
Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience  Andy I. Chen, Alex McMillan,
Optimal Donor Selection: Beyond HLA
Radiation Disasters: Role of the BMT Team
Presentation transcript:

8/8 and 10/10 High-Resolution Match Rate for the Be The Match Unrelated Donor Registry  Jason Dehn, Kelly Buck, Martin Maiers, Dennis Confer, Robert Hartzman, Craig Kollman, Alexander H. Schmidt, Soo Young Yang, Michelle Setterholm  Biology of Blood and Marrow Transplantation  Volume 21, Issue 1, Pages 137-141 (January 2015) DOI: 10.1016/j.bbmt.2014.10.002 Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 2009 registry. Pre (initial search results) and post (after donor HLA typing) typing 8/8 HR match rate by race. Indeterminate in “pre” typing columns is defined as PP with potential URD to match at 8/8 but further typing is required. Indeterminate in “post” typing columns is defined as PP without a defined 8/8 match and additional URD remain untested. WH indicates White; HIS, Hispanic; API, Asian/Pacific Islander; AFA, African American/Black. Biology of Blood and Marrow Transplantation 2015 21, 137-141DOI: (10.1016/j.bbmt.2014.10.002) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 2009 registry. Selection of URD to identify an 8/8 match by PP race. Displays the number of typed donors out of total 8/8 potential donors (shown on log 10 scale) listed on a PP search. “No match identified after typing” includes PP cases where some URD remained untested. (A) WH: 87% of the WH PP subset with an 8/8 match identified via HLA typing (n = 118) required 2 or fewer URD selections, and 94% of all WH PP identifying a match (existing and via typing; n = 258) required 2 or fewer URD selections. (B) HIS: 98% of the HIS PP subset with an 8/8 match identified via HLA typing (n = 91) required 2 or fewer URD selections, and 98% of all HIS PP identifying a match (existing and via typing; n = 127) required 2 or fewer URD selections. (C) API: 91% of the API PP subset with an 8/8 match identified via HLA typing (n = 93) required 2 or fewer URD selections, and 93% of all API PP identifying a match (existing and via typing; n = 120) required 2 or fewer URD selections. (D) AFA: 99% of the AFA PP subset with an 8/8 match identified via HLA typing (n = 84) required 2 or fewer URD selections, and 99% of all AFA PP identifying a match (existing and via typing; n = 105) required 2 or fewer URD selections. Biology of Blood and Marrow Transplantation 2015 21, 137-141DOI: (10.1016/j.bbmt.2014.10.002) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 2012 Registry: 10/10 HR match rate by race. Indeterminate is defined as PP without an identified 10/10 match and additional URD remain untested. WH indicates White; HIS, Hispanic; API, Asian/Pacific Islander; AFA, African American/Black. Biology of Blood and Marrow Transplantation 2015 21, 137-141DOI: (10.1016/j.bbmt.2014.10.002) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions